• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌筛查的十个重要注意事项。

Ten Important Considerations for Ovarian Cancer Screening.

作者信息

Pavlik Edward J

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Kentucky Chandler Medical Center and the Markey Cancer Center, Lexington, KY 40536-0293, USA.

出版信息

Diagnostics (Basel). 2017 Apr 13;7(2):22. doi: 10.3390/diagnostics7020022.

DOI:10.3390/diagnostics7020022
PMID:28406427
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5489942/
Abstract

The unique intricacies of ovarian cancer screening and perspectives of different screening methods are presented as ten considerations that are examined. Included in these considerations are: These considerations are presented in depth along with illustrations of how they impact the outcomes of ovarian cancer screening. The considerations presented provide alternative explanations of effects that have an important bearing on interpreting ovarian screening outcomes.

摘要

本文介绍了卵巢癌筛查的独特复杂性以及不同筛查方法的观点,并将其作为十个需要考量的方面进行了探讨。这些考量包括:文中对这些考量进行了深入阐述,并举例说明了它们如何影响卵巢癌筛查的结果。所提出的考量为影响卵巢癌筛查结果解读的效应提供了其他解释。

相似文献

1
Ten Important Considerations for Ovarian Cancer Screening.卵巢癌筛查的十个重要注意事项。
Diagnostics (Basel). 2017 Apr 13;7(2):22. doi: 10.3390/diagnostics7020022.
2
Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.基于超声的家族性卵巢癌筛查诊所的结果:一项10年观察性研究。
Ultrasound Obstet Gynecol. 2003 Apr;21(4):378-85. doi: 10.1002/uog.65.
3
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.在英国家族性卵巢癌筛查研究的第二阶段中,被诊断为卵巢癌的女性出现分期转移的证据。
J Clin Oncol. 2017 May 1;35(13):1411-1420. doi: 10.1200/JCO.2016.69.9330. Epub 2017 Feb 27.
4
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
5
6
7
Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.家族性卵巢癌筛查:根据国际妇产科联合会系统,当前方案未能在早期检测出卵巢癌。
J Clin Oncol. 2005 Aug 20;23(24):5588-96. doi: 10.1200/JCO.2005.05.097.
8
Mammography screening: A major issue in medicine.乳腺 X 光筛查:医学中的一个重大问题。
Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20.
9
Biology of epithelial ovarian cancer: implications for screening women at high genetic risk.上皮性卵巢癌的生物学特性:对高遗传风险女性筛查的意义。
J Clin Oncol. 2004 Apr 1;22(7):1315-27. doi: 10.1200/JCO.2004.07.179.
10
A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy.BRCA1 突变女性行年度超声筛查与预防性卵巢切除术后卵巢癌死亡率比较
Gynecol Oncol. 2019 Nov;155(2):270-274. doi: 10.1016/j.ygyno.2019.08.034. Epub 2019 Sep 26.

引用本文的文献

1
Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel.采用联合蛋白生物标志物面板诊断上皮性卵巢癌。
Br J Cancer. 2019 Sep;121(6):483-489. doi: 10.1038/s41416-019-0544-0. Epub 2019 Aug 7.
2
The Effects of the Dietary and Nutrient Intake on Gynecologic Cancers.饮食和营养摄入对妇科癌症的影响。
Healthcare (Basel). 2019 Jul 7;7(3):88. doi: 10.3390/healthcare7030088.
3
Ovarian Cancer Screening: Lessons about Effectiveness.卵巢癌筛查:关于有效性的经验教训

本文引用的文献

1
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.在英国家族性卵巢癌筛查研究的第二阶段中,被诊断为卵巢癌的女性出现分期转移的证据。
J Clin Oncol. 2017 May 1;35(13):1411-1420. doi: 10.1200/JCO.2016.69.9330. Epub 2017 Feb 27.
2
Ovarian cancer screening effectiveness: A realization from the UK Collaborative Trial of Ovarian Cancer Screening.卵巢癌筛查的有效性:来自英国卵巢癌筛查协作试验的一项认识
Womens Health (Lond). 2016 Sep;12(5):475-479. doi: 10.1177/1745505716666096. Epub 2016 Sep 5.
3
Clinical Efficacy of Ovarian Cancer Screening.
Diagnostics (Basel). 2017 Dec 29;8(1):1. doi: 10.3390/diagnostics8010001.
卵巢癌筛查的临床疗效
J Cancer. 2016 Jun 25;7(10):1311-6. doi: 10.7150/jca.14615. eCollection 2016.
4
Evaluation and Management of Ultrasonographically Detected Ovarian Tumors in Asymptomatic Women.无症状妇女超声检查发现的卵巢肿瘤的评估和管理。
Obstet Gynecol. 2016 May;127(5):848-858. doi: 10.1097/AOG.0000000000001384.
5
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.英国卵巢癌筛查协作试验(UKCTOCS)中的卵巢癌筛查与死亡率:一项随机对照试验
Lancet. 2016 Mar 5;387(10022):945-956. doi: 10.1016/S0140-6736(15)01224-6. Epub 2015 Dec 17.
6
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.卵巢癌女性中BRIP1、BARD1、PALB2和NBN基因的种系突变
J Natl Cancer Inst. 2015 Aug 27;107(11). doi: 10.1093/jnci/djv214. Print 2015 Nov.
7
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.RAD51B、RAD51C和RAD51D基因种系突变对人群卵巢癌的影响。
J Clin Oncol. 2015 Sep 10;33(26):2901-7. doi: 10.1200/JCO.2015.61.2408. Epub 2015 Aug 10.
8
Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.美国国立癌症研究所综合癌症中心对卵巢癌治疗及生存的影响。
J Am Coll Surg. 2015 May;220(5):940-50. doi: 10.1016/j.jamcollsurg.2015.01.056. Epub 2015 Feb 14.
9
Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.遵循指南对早期上皮性卵巢癌患者预后的影响。
Eur J Surg Oncol. 2015 Apr;41(4):585-91. doi: 10.1016/j.ejso.2015.01.006. Epub 2015 Jan 17.
10
Ovarian cancer in the United States: contemporary patterns of care associated with improved survival.美国的卵巢癌:与生存率提高相关的当代护理模式
Gynecol Oncol. 2015 Jan;136(1):11-7. doi: 10.1016/j.ygyno.2014.10.023. Epub 2014 Oct 29.